The letter to DeSantis comes after a joint meeting of Crist’s and Bilirakis’ Veteran Advisory Boards raised concerns that veteran suicide data may not be as accurate as it should be. Crist and Bilirakis represent the more than 110,000 veterans.
“Our priority is advocating for Floridians who have felt the pinch in their wallets because profit-driven policies by PBMs are robbing patients of savings that should rightly be theirs,” said Toledo.
U.S. Rep. Gus Bilirakis, R-Fla., is behind a bipartisan push on Capitol Hill to bring more medical technology in treating Americans on Medicare.
Two Republicans from Northeast Florida serving in the Legislature--state Sen. Aaron Bean, R-Fernandina Beach and state Rep. Jason Fischer, R-Jacksonville--teamed up on Tuesday to push for funds to help around 100 Holocaust survivors on the First Coast.
Noting the continued opioid crisis, Central Florida congresswoman is behind a bill to reform how Medicaid and the Children’s Health Insurance Program (CHIP) covers addiction treatment.
Floridians Against Recreational Marijuana (FARM) was launched “to combat the mega-marijuana, out-of-state corporate interests driving the 2020 ballot initiative attempting to bring recreational marijuana to Florida.”
The Florida Legislature and executive regulatory agencies set certain parameters around fees that companies can charge for specific services. Where the rubber meets the road is when those fees determine whether a company can continue to provide said services under the fee limitations.
On Tuesday, U.S. Rep. Ross Spano, R-Fla., paired up with a Democratic presidential candidate to bring out a bill to reform TRICARE for National Guard and Reserve personnel.
There has been much discussion and debate recently about pharmacy benefit managers (PBMs), specifically suggesting that they’re responsible for the increased drug prices that Florida’s seniors are facing. These are serious claims that deserve some very close scrutiny.
The two senators have introduced the “We PAID Act” which would ensure that the prices of drugs developed using federally funded research are set at reasonable levels. The legislation has been endorsed by AARP.